Sanctuary Advisors LLC Makes New Investment in Chemed Corporation $CHE

Sanctuary Advisors LLC bought a new stake in shares of Chemed Corporation (NYSE:CHE) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,053 shares of the company’s stock, valued at approximately $490,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CHE. Geneos Wealth Management Inc. boosted its position in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after acquiring an additional 76 shares during the period. Arrowstreet Capital Limited Partnership raised its holdings in shares of Chemed by 67.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock valued at $5,534,000 after purchasing an additional 4,560 shares in the last quarter. Marshall Wace LLP acquired a new stake in shares of Chemed in the second quarter worth about $579,000. Brown Advisory Inc. boosted its position in Chemed by 36.9% during the second quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock worth $267,000 after purchasing an additional 148 shares during the period. Finally, Cerity Partners LLC boosted its holdings in shares of Chemed by 237.7% during the 2nd quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock worth $2,165,000 after buying an additional 3,133 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Up 0.6%

NYSE:CHE opened at $523.57 on Friday. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $557.00. The firm has a market capitalization of $6.84 billion, a P/E ratio of 26.30, a P/E/G ratio of 1.98 and a beta of 0.51. The stock’s fifty day simple moving average is $509.45 and its 200-day simple moving average is $449.67.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.Chemed’s revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the business posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities research analysts expect that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be paid a $0.70 dividend. The ex-dividend date of this dividend is Monday, August 17th. This is a positive change from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. Chemed’s payout ratio is presently 14.06%.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Oppenheimer increased their target price on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Bank of America reiterated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Royal Bank Of Canada upped their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $530.75.

Insiders Place Their Bets

In other Chemed news, EVP Spencer S. Lee sold 1,000 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the completion of the transaction, the executive vice president owned 13,912 shares in the company, valued at approximately $7,526,948.48. This represents a 6.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 6,537 shares of company stock valued at $3,406,014 over the last 90 days. 3.33% of the stock is owned by company insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.